187 related articles for article (PubMed ID: 32892198)
1. The Role of 2D/3D Ultrasound to Assess the Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer.
Perniola G; Tomao F; Graziano M; Palaia I; Fischetti M; Lecce F; Casorelli A; Di Donato V; Giancotti A; Battaglia FA; Muzii L; Benedetti Panici P
Oncology; 2020; 98(11):807-813. PubMed ID: 32892198
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Parametrial Status in Locally Advanced Cervical Cancer Patients after Neoadjuvant Chemotherapy: A Prospective Study on Diagnostic Accuracy of Three-Dimensional Transvaginal Ultrasound.
Perniola G; Fischetti M; Tomao F; Di Donato V; Palaia I; Santangelo G; Lecce F; Piccioni MG; Muzii L; Benedetti Panici P
Oncology; 2020; 98(9):603-611. PubMed ID: 32492692
[TBL] [Abstract][Full Text] [Related]
3. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Ferrandina G; Moro F; Pasciuto T; Moruzzi MC; De Blasis I; Mascilini F; Foti E; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta MA; Valentini AL; Rufini V; Scambia G
Ultrasound Obstet Gynecol; 2018 May; 51(5):684-695. PubMed ID: 28620930
[TBL] [Abstract][Full Text] [Related]
4. Value of three-dimensional power Doppler to predict clinical and histological response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Qin J; Cheng X; Chen X; Zhang X; Lu W; Xie X
Ultrasound Obstet Gynecol; 2012 Feb; 39(2):226-34. PubMed ID: 21845741
[TBL] [Abstract][Full Text] [Related]
5. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer.
Pinkavova I; Fischerova D; Zikan M; Burgetova A; Slama J; Svarovsky J; Dundr P; Dusek L; Cibula D
Ultrasound Obstet Gynecol; 2013 Dec; 42(6):705-12. PubMed ID: 23495185
[TBL] [Abstract][Full Text] [Related]
6. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
Ditto A; Longo M; Chiarello G; Mariani L; Paolini B; Leone Roberti Maggiore U; Martinelli F; Bogani G; Raspagliesi F
Eur J Surg Oncol; 2024 Jun; 50(6):108311. PubMed ID: 38554552
[TBL] [Abstract][Full Text] [Related]
7. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.
Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R
Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484
[TBL] [Abstract][Full Text] [Related]
9. Is magnetic resonance imaging useful in early evaluation of women on neoadjuvant chemotherapy for locally advanced cervical cancer?
Sala P; Marchiolè P; Cittadini G; Valenzano Menada M; Moioli M; Mammoliti S; Costantini S
Eur J Gynaecol Oncol; 2012; 33(1):31-6. PubMed ID: 22439402
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
11. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
12. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer.
Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T
Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): a study protocol of a prospective, single-arm, phase II trial.
Chen J; Han Y; Hu Y; Feng X; Meng X; Guo S; Sun C; Chen G; Li K
BMJ Open; 2023 May; 13(5):e067767. PubMed ID: 37253491
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects of irinotecan hydrochloride in combination with cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.
Xiong Y; Liang LZ; Cao LP; Min Z; Liu JH
Gynecol Oncol; 2011 Oct; 123(1):99-104. PubMed ID: 21741694
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.
Kumar JV; Doval DC; Rao R; Rawal S
Int J Gynecol Cancer; 2009 Apr; 19(3):417-22. PubMed ID: 19407570
[TBL] [Abstract][Full Text] [Related]
16. Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.
Arezzo F; Cormio G; Mongelli M; Cazzato G; Silvestris E; Kardhashi A; Cazzolla A; Lombardi C; Venerito V; Loizzi V
Arch Gynecol Obstet; 2023 Jun; 307(6):1911-1919. PubMed ID: 36370209
[TBL] [Abstract][Full Text] [Related]
17. PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to assess residual tumor in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery.
Testa AC; Moro F; Pasciuto T; Moruzzi MC; Di Legge A; Fuoco G; Autorino R; Collarino A; Gui B; Zannoni GF; Gambacorta A; Miccò M; Rufini V; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2018 Jul; 52(1):110-118. PubMed ID: 29119649
[TBL] [Abstract][Full Text] [Related]
18. Basic T1 Perfusion magnetic resonance imaging evaluation of the therapeutic effect of neoadjuvant chemotherapy in locally advanced cervical cancer.
Fu C; Feng X; Bian D; Du W; Wang X; Zhao Y
Int J Gynecol Cancer; 2013 Sep; 23(7):1270-8. PubMed ID: 23970155
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract][Full Text] [Related]
20. [Transvaginal color-Doppler sonography for monitoring the response to neoadjuvant chemotherapy in patients with locally advanced cervical cancer].
Di Vagno G; Cormio G; Vimercati A; Nacci G; Greco P; Lepera A; Loverro G; Selvaggi L
Minerva Ginecol; 1996 Nov; 48(11):463-7. PubMed ID: 9005372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
